title: PGJ2 restores RA sensitivity in melanoma cells by decreasing PRAME and EZH2.
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 12, Nice, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Pierron
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 12, Nice, France.
authors.forename: Elodie
authors.initials: E
authors.lastname: Le Pape
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 12, Nice, France; University Hospital of Nice, Department of Dermatology, Nice, France.
authors.forename: Henri
authors.initials: H
authors.lastname: Montaudié
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 12, Nice, France; University Hospital of Nice, Department of Dermatology, Nice, France.
authors.forename: Emeline
authors.initials: E
authors.lastname: Castela
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 12, Nice, France.
authors.forename: Gian Marco
authors.initials: GM
authors.lastname: De Donatis
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 1, Nice, France.
authors.forename: Maryline
authors.initials: M
authors.lastname: Allegra
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 1, Nice, France.
authors.forename: Corine
authors.initials: C
authors.lastname: Bertolotto
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 1, Nice, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Rocchi
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 1, Nice, France.
authors.forename: Yann
authors.initials: Y
authors.lastname: Cheli
authors.affiliation: University Hospital of Nice, Department of Dermatology, Nice, France; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 1, Nice, France.
authors.forename: Robert
authors.initials: R
authors.lastname: Ballotti
authors.affiliation: INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), team 12, Nice, France; University Hospital of Nice, Department of Dermatology, Nice, France. Electronic address: passeron@unice.fr.
authors.forename: Thierry
authors.initials: T
authors.lastname: Passeron
mesh_terms: D000951:Antigens, Neoplasm / Q000032:analysis / Q000502:physiology*; D045744:Cell Line, Tumor; D000071221:Enhancer of Zeste Homolog 2 Protein; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D063151:Polycomb Repressive Complex 2 / Q000032:analysis / Q000502:physiology*; D015230:Prostaglandin D2 / Q000031:analogs & derivatives* / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D000951:Antigens, Neoplasm; C404944:PRAME protein, human; D014212:Tretinoin; C037112:9-deoxy-delta-9-prostaglandin D2; C498409:EZH2 protein, human; D000071221:Enhancer of Zeste Homolog 2 Protein; D063151:Polycomb Repressive Complex 2; D015230:Prostaglandin D2